Oxelumab
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | OX-40 ligand |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6424H9920N1704O2014S42 |
Molar mass | 144594.46 g·mol−1 |
![]() ![]() |
Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]
Oxelumab was developed by Genentech and co-developed by Roche.
References
Categories:
- Drugs not assigned an ATC code
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Drugs that are a monoclonal antibody
- Hoffmann-La Roche brands
- Genentech brands
- Experimental drugs
- All stub articles
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs